1-5 of 5
Alina Berriolo-Riedinger
Close
Sort by
Journal Articles

High PDL1/PDL2 gene expression correlates with worse outcome in primary mediastinal large B-cell lymphoma

Vincent Camus, Pierre-Julien Viailly, Fanny Drieux, Elena-Liana Veresezan, Pierre Sesques, Corinne Haioun, Eric Durot, Martine Patey, Cédric Rossi, Laurent Martin, Vinciane Rainville, Elodie Bohers, Philippe Ruminy, Dominique Penther, Sophie Kaltenbach, Julie Bruneau, Jérome Paillassa, Olivier Tournilhac, Alexandre Willaume, Chloé Antier, Julien Lazarovici, Emilie Lévêque, Pierre Decazes, Stéphanie Becker, David Tonnelet, Alina Berriolo-Riedinger, Philippe Gaulard, Hervé Tilly, Thierry Jo Molina, Alexandra Traverse-Glehen, Fabrice Jardin
Journal: Blood Advances
Blood Adv (2023) 7 (23): 7331–7345.
https://doi.org/10.1182/bloodadvances.2023011169
Published: 2023
Includes: Supplemental data
Journal Articles

A tumor volume and performance status model to predict outcome before treatment in diffuse large B-cell lymphoma

Catherine Thieblemont, Loic Chartier, Ulrich Dührsen, Umberto Vitolo, Sally F. Barrington, Jan M. Zaucha, Laetitia Vercellino, Maria Gomes Silva, Ines Patrocinio-Carvalho, Pierre Decazes, Pierre-Julien Viailly, Herve Tilly, Alina Berriolo-Riedinger, Oliver Casasnovas, Andreas Hüttmann, Hajira Ilyas, N. George Mikhaeel, Joel Dunn, Anne-Ségolène Cottereau, Christine Schmitz, Lale Kostakoglu, Joseph N. Paulson, Tina Nielsen, Michael Meignan
Journal: Blood Advances
Blood Adv (2022) 6 (23): 5995–6004.
https://doi.org/10.1182/bloodadvances.2021006923
Published: 2022
Includes: Supplemental data
Journal Articles

Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study

Clinical Trials & Observations
Vincent Camus, Cédric Rossi, Pierre Sesques, Justine Lequesne, David Tonnelet, Corinne Haioun, Eric Durot, Alexandre Willaume, Martin Gauthier, Marie-Pierre Moles-Moreau, Chloé Antier, Julien Lazarovici, Hélène Monjanel, Sophie Bernard, Magalie Tardy, Caroline Besson, Laure Lebras, Sylvain Choquet, Katell Le Du, Christophe Bonnet, Sarah Bailly, Ghandi Damaj, Kamel Laribi, Hervé Maisonneuve, Roch Houot, Adrien Chauchet, Fabrice Jardin, Alexandra Traverse-Glehen, Pierre Decazes, Stéphanie Becker, Alina Berriolo-Riedinger, Hervé Tilly
Journal: Blood Advances
Blood Adv (2021) 5 (19): 3862–3872.
https://doi.org/10.1182/bloodadvances.2021004778
Published: 2021
Includes: Supplemental data
Journal Articles

Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma

Clinical Trials & Observations
Laetitia Vercellino, Roberta Di Blasi, Salim Kanoun, Benoit Tessoulin, Cedric Rossi, Maud D'Aveni-Piney, Lucie Obéric, Caroline Bodet-Milin, Pierre Bories, Pierre Olivier, Ingrid Lafon, Alina Berriolo-Riedinger, Eugenio Galli, Sophie Bernard, Marie-Thérèse Rubio, Celine Bossard, Veronique Meignin, Pascal Merlet, Pierre Feugier, Steven Le Gouill, Loic Ysebaert, Olivier Casasnovas, Michel Meignan, Sylvie Chevret, Catherine Thieblemont
Journal: Blood Advances
Blood Adv (2020) 4 (22): 5607–5615.
https://doi.org/10.1182/bloodadvances.2020003001
Published: 2020
Includes: Supplemental data
Journal Articles

Total metabolic tumor volume, circulating tumor cells, cell-free DNA: distinct prognostic value in follicular lymphoma

Clinical Trials & Observations
Marie-Hélène Delfau-Larue, Axel van der Gucht, Jehan Dupuis, Jean-Philippe Jais, Isabelle Nel, Asma Beldi-Ferchiou, Salma Hamdane, Ichrafe Benmaad, Gaelle Laboure, Benjamin Verret, Corinne Haioun, Christiane Copie-Bergman, Alina Berriolo-Riedinger, Philippine Robert, René-Olivier Casasnovas, Emmanuel Itti
Journal: Blood Advances
Blood Adv (2018) 2 (7): 807–816.
https://doi.org/10.1182/bloodadvances.2017015164
Published: 2018
Includes: Supplemental data